Cover Image
市場調查報告書

美國:切片檢查市場 & 數量分析 2020年

United States - Biopsy Testing Market & Volume Analysis to 2020

出版商 Renub Research 商品編碼 349637
出版日期 內容資訊 英文 53 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
美國:切片檢查市場 & 數量分析 2020年 United States - Biopsy Testing Market & Volume Analysis to 2020
出版日期: 2016年01月12日 內容資訊: 英文 53 Pages
簡介

美國的切片檢查市場2014年超過150億美元,未來預測更加樂觀。在2014年美國的切片檢查市場中,乳癌成為最許多市場區隔。甲狀腺癌雖位於最後一名,不過,甲狀腺癌是美國最劇增的癌症種類。可是從數量分析的話,前列腺癌是最大的市場區隔。美國的癌症盛行率,由於老年人口的增加及微創治療的需求高漲,預計促進在預測期間內的市場成長。

本報告提供美國的切片檢查市場相關的總括性調查、癌症的5大市場區隔的市場分析與數量的預測、切片檢查市場促進要素與課題分析等相關資料彙整。

第1章 摘要整理

第2章 美國的切片檢查市場:數量、預測

  • 市場 & 預測
  • 數量 & 預測

第3章 美國的切片檢查市場 & 數量佔有率分析

  • 市場佔有率 & 預測
  • 數量佔有率 & 預測

第4章 美國的切片檢查市場 & 數量預測:檢驗市場區隔分析

  • 前列腺癌
  • 乳癌
  • 肺癌
  • 肝癌
  • 甲狀腺癌

第5章 美國的切片檢查市場:促進成長要素

  • 對特定的癌症來說不完全的檢驗
  • 微創切片檢查技術的需求
  • 切片檢查技術的進步
    • 前列腺癌
    • 乳癌
    • 肺癌
    • 肝癌
    • 甲狀腺癌

第6章 美國的切片檢查市場:課題

  • 胸部切片檢查醫療費償付的商品搭售
  • 切片檢查的限制

圖表

目錄

United States Biopsy Test Market was more than US$ 15 Billion in 2014 and future seems to be much brighter. In the United States Biopsy Test Market, Breast Cancer is the most popular segment in 2014. Thyroid cancer stands at the last spot, but it is the most rapidly increasing type of cancer in the United States. However if we make the analysis from the Volume point then Prostate Cancer is the most popular segment. Increasing United States prevalence of cancer, geriatric population and increasing demand for minimally invasive procedures are expected to drive market growth during the forecast period.

Renub Research report titled "United States - Biopsy Testing Market & Volume Analysis to 2020 " provides a comprehensive assessment of the fast-evolving, high-growth of Biopsy Market. This 53 page report with 28 Figures and 1 Table analyses the United States Biopsy Test Market and Volume by 5 Top Cancer Segment, driving factors and challenges for Biopsy market.

The United States Biopsy Market has been analyzed from two view points

  • United States Biopy Test Market & Forecast (2008 - 2020)
  • United States Biopy Test Volume & Forecast (2008 - 2020)

The Top 5 Cancer Segments covered are:

  • 1. Breast Cancer
  • 2. Prostate Cancer
  • 3. Liver Cancer
  • 4. Lung Cancer
  • 5. Thyroid Cancer

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Renub Research team of industry experts.

Primary sources include industry surveys and telephone interviews with industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 500 paid databases.

Table of Contents

1. Executive Summary

2. United States Biopsy Test Market, Volume & Forecast (2008 - 2020)

  • 2.1 United States Biopsy Test Market & Forecast
  • 2.2 United States Biopsy Test Volume & Forecast

3. United States Biopsy Test Market & Volume Share Analysis (2008 - 2020)

  • 3.1 United States Biopsy Test Market Share & Forecast
  • 3.2 United States Biopsy Test Volume Share & Forecast

4. United States Biopsy Market & Volume Forecast - Test Segment Analysis (2008 - 2020)

  • 4.1 United States - Prostate Cancer Biopsy Test Market & Volume Forecast
    • 4.1.1 United States - Prostate Cancer Biopsy Test Market & Forecast
    • 4.1.2 United States - Prostate Cancer Biopsy Test Volume & Forecast
  • 4.2 United States - Breast Cancer Biopsy Test Market & Volume Forecast
    • 4.2.1 United States - Breast Cancer Biopsy Test Market & Forecast
    • 4.2.2 United States - Breast Cancer Biopsy Test Volume & Forecast
  • 4.3 United States - Lung Cancer Biopsy Test Market & Volume Forecast
    • 4.3.1 United States - Lung Cancer Biopsy Test Market & Forecast
    • 4.3.2 United States - Lung Cancer Biopsy Test Volume & Forecast
  • 4.4 United States - Liver Cancer Biopsy Test Market & Volume Forecast
    • 4.4.1 United States - Liver Cancer Biopsy Test Market & Forecast
    • 4.4.2 United States - Liver Cancer Biopsy Test Volume & Forecast
  • 4.5 United States - Thyroid Cancer Biopsy Test Market & Volume Forecast
    • 4.5.1 United States - Thyroid Cancer Biopsy Test Market & Forecast
    • 4.5.2 United States - Thyroid Cancer Biopsy Test Volume & Forecast

5. United States Biopsy Test Market - Growth Drivers

  • 5.1 Inadequate Screening Tests for Particular Cancers
  • 5.2 Demand for Minimally-Invasive Biopsy Techniques
  • 5.3 Advancement in Biopsy Techniques
    • 5.3.1 Advances in Prostate Biopsy Techniques
    • 5.3.2 Advances in Breast Biopsy Techniques
    • 5.3.3 Advances in Lung Biopsy Techniques
    • 5.3.4 Advances in Liver Biopsy Techniques
    • 5.3.5 Advances in Thyroid Biopsy Techniques

6. United States Biopsy Test Market - Challenges

  • 6.1 Breast Biopsy Reimbursement Bundling
  • 6.2 Biopsy Limitations

List of Figures:

  • Figure 2-1: United States - Biopsy Test Market (Million US$), 2008 - 2014
  • Figure 2-2: United States - Forecast for Biopsy Test Market (Million US$), 2015 - 2020
  • Figure 2-3: United States - Biopsy Test Volume (Thousand), 2008 - 2014
  • Figure 2-4: United States - Forecast for Biopsy Test Volume (Thousand), 2015 - 2020
  • Figure 3-1: United States - Biopsy Test Market Share (Percent), 2008 - 2014
  • Figure 3-2: United States - Forecast for Biopsy Test Market Share (Percent), 2015 - 2020
  • Figure 3-3: United States - Biopsy Test Volume Share (Percent), 2008 - 2014
  • Figure 3-4: United States - Forecast for Biopsy Test Volume Share (Percent), 2015 - 2020
  • Figure 4-1: United States - Prostate Cancer Biopsy Test Market (Million US$), 2008 - 2014
  • Figure 4-2: United States - Forecast for Prostate Cancer Biopsy Test Market (Million US$), 2015 -2020
  • Figure 4-3: United States - Prostate Cancer Biopsy Test Volume (Thousand), 2008 - 2014
  • Figure 4-4: United States - Forecast for Prostate Cancer Biopsy Test Volume (Thousand), 2015 - 2020
  • Figure 4-5: United States - Breast Cancer Biopsy Test Market (Million US$), 2008 - 2014
  • Figure 4-6: United States - Forecast for Breast Cancer Biopsy Test Market (Million US$), 2015 - 2020
  • Figure 4-7: United States - Breast Cancer Biopsy Test Volume (Thousand), 2008 - 2014
  • Figure 4-8: United States - Forecast for Breast Cancer Biopsy Test Volume (Thousand), 2015 - 2020
  • Figure 4-9: United States - Lung Cancer Biopsy Test Market (Million US$), 2008 - 2014
  • Figure 4-10: United States - Forecast for Lung Cancer Biopsy Test Market (Million US$), 2015 - 2020
  • Figure 4-11: United States - Lung Cancer Biopsy Test Volume (Thousand), 2008 - 2014
  • Figure 4-12: United States - Forecast for Lung Cancer Biopsy Test Volume (Thousand), 2015 - 2020
  • Figure 4-13: United States - Liver Cancer Biopsy Test Market (Million US$), 2008 - 2014
  • Figure 4-14: United States - Forecast for Liver Cancer Biopsy Test Market (Million US$), 2015 - 2020
  • Figure 4-15: United States - Liver Cancer Biopsy Test Volume (Thousand), 2008 - 2014
  • Figure 4-16: United States - Forecast for Liver Cancer Biopsy Test Volume (Thousand), 2015 - 2020
  • Figure 4-17: United States - Thyroid Cancer Biopsy Test Market (Million US$), 2008 - 2014
  • Figure 4-18: United States - Forecast for Thyroid Cancer Biopsy Test Market (Million US$), 2015 -2020
  • Figure 4-19: United States - Thyroid Cancer Biopsy Test Volume (Thousand), 2008 - 2014
  • Figure 4-20: United States - Forecast for Thyroid Cancer Biopsy Test Volume (Thousand), 2015 -2020

List of Tables:

  • Table 6-1: Breast Biopsy - Final Medicare Physician Fee Schedule, 2015
Back to Top